GBP1 and ovarian carcinoma: Lastly, the roles of guanylate‐binding protein 1 (GBP1) in cancer are seemingly context‐dependent, since its upregulation was associated with decreased progression in breast and colorectal cancer, but increased progression, metastasis, and resistance in ovarian cancer and glioblastoma [84].